Idexx Laboratories Latin America & Caribbean — Total Revenue increased by 0.8% to $23.22M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 16.2%, from $19.99M to $23.22M. This is a positive signal — higher values indicate stronger performance for this metric.
An increase indicates successful market expansion, higher adoption of diagnostic technology, or improved distribution efficiency in the region. A decrease may signal competitive pressure, economic volatility, or challenges in local veterinary market penetration.
This metric represents the total gross revenue generated from the sale of diagnostic products, equipment, and veterinary...
Comparable to regional revenue segments for other global life sciences or medical device companies, often benchmarked against regional GDP growth and veterinary healthcare spending trends.
idxx_segment_latin_america_caribbean_total_revenue| Q2 '21 | Q3 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $16.39M | $17.07M | $17.74M | $19.10M | $18.69M | $19.45M | $20.82M | $21.35M | $20.24M | $21.32M | $20.98M | $19.99M | $22.33M | $23.04M | $23.22M |
| QoQ Change | — | +4.1% | +3.9% | +7.6% | -2.1% | +4.1% | +7.0% | +2.6% | -5.2% | +5.3% | -1.6% | -4.7% | +11.7% | +3.2% | +0.8% |
| YoY Change | — | — | — | +16.5% | +9.5% | +9.6% | +9.0% | +14.2% | +4.1% | +2.4% | -1.7% | -1.3% | +4.7% | +9.8% | +16.2% |